Latest Biotech Startup Funding Rounds

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma.

Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.

A Copenhagen crop-protection biotech developing protein-based pest-control products designed to target specific agricultural pests while reducing harm to beneficial insects and reliance on conventional pesticides.

A biotechnology company producing gene-edited donor pigs for research and planned clinical trials in organ transplantation.

Vaxdyn develops vaccines against antimicrobial-resistant bacteria, including its lead candidate K-VAX for Klebsiella pneumoniae and Acinetobacter baumannii.

A biotechnology company developing siRNA medicines designed to suppress disease-causing mutations while preserving normal gene function.

Helogen builds autonomous in-orbit manufacturing systems for biomaterials and biologics.

MOA Foodtech uses AI-guided fermentation to turn agricultural and food-processing byproducts into functional protein and ingredient products for food and pet-food manufacturers. Its models help select suitable microorganisms and process conditions for each feedstock; the company also offers custom development and modular systems for valorising starch-rich side streams.